Is the myofibrillarlytic myocyte a forme fruste apoptotic myocyte?

Annals of Thoracic Surgery

Volumn 79, Issue 4, 2005, Pages 1333-1337

  Narula, Navneet ^b   Narula, Jagat ^a   Zhang, Paul J ^b   Haider, Nezam ^b   Raghunath, Puthiyaveettil N ^b   Brittin, Robin ^b   Gorman III, Joseph H ^b   Gorman, Robert C ^b   Tomaszewski, John E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CELL NUCLEUS MEMBRANE; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; ENDOCARDIUM; HEART GRAFT; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOFIBRILLARLYTIC MYOCYTE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; UPREGULATION;

EID: 15944401711     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.09.061     Document Type: Article

References (26)

1. D.V. Unverferth, R.D. Magorien, R.P. Lewis, C.V. Leier The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy Am Heart J 105 1983 176 179
2. G.M. Edwalds, J.W. Said, M.I. Block, L.L. Herscher, R.J. Siegel, M.C. Fishbein Myocytolysis (vacuolar degeneration) of myocardium: immunohistochemical evidence of viability Hum Pathol 15 1984 753 756
3. J. Narula, J.F. Southern, G.W. Dec Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy J Nucl Cardiol 2 1995 470 477
4. M.A. Friedman, M.J. Bozdech, M.E. Billingham, A.K. Rider Doxorubicin cardiotoxicity Serial endomyocardial biopsies and systolic time intervals JAMA 240 1978 1603 1606
5. J. Narula, N. Haider, R. Virmani Apoptosis in myocytes in end-stage heart failure N Engl J Med 335 1996 1182 1189
6. G. Itoh, J. Tamura, M. Suzuki DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis Am J Path 146 1995 1325 1331
7. J. Narula, S. Kharbanda, B.A. Khaw Apoptosis of the heart Chest 112 1997 1358 1362
8. E.R. Schwarz, J. Schaper, J. vom Dahl Myocyte degeneration and cell death in hibernating human myocardium Am Coll Cardiol 27 1996 1577 1585
9. N. Haider, S. Kharbanda, Y. Chandrashekhar Caspase-3 mediated cleavage of troponin-C at evolutionarily-conserved calcium-binding site Circulation 100 1999 I-283
10. C. Communal, M. Sumandea, P. de Tombe, J. Narula, R.J. Solaro, R.J. Hajjar Functional consequences of caspase activation in cardiac myocytes Proc Natl Acad Sci USA 99 2002 6252 6256
11. Y. Gavrielli, Y. Sherman, S.A. Ben-Sasson Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol 119 1992 493 501
12. F.D. Kolodgie, J. Narula, A.P. Burke Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death Am J Pathol 157 2000 1259 1268
13. L. Gorza, R. Menabo, F. Di Lisa, M. Vitadello Troponin T cross-linking in human apoptotic cardiomyocytes Am J Pathol 150 1997 2087 2097
14. Y. Chandrashekhar, S. Sen, R. Anway, A. Shuros, I.S. Anand Long-term caspase inhibition ameliorates apoptosis, reduces troponin-I cleavage, protects LV function and attenuates remodeling in rats with myocardial infarction J Am Coll Cardiol 43 2004 295 301
15. W.D. Gao, D. Atar, Y. Liu, N.G. Perez, A.M. Murphy, E. Marban Role of troponin I proteolysis in the pathogenesis of stunned myocardium Circ Res 80 1997 393 399
16. A.M. Murphy, H. Kogler, D. Georgakopoulos Transgenic mouse model of stunned myocardium Science 287 2000 488 491
17. M. Kanoh, G. Takemura, J. Misao Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair [see comments.] [Clinical Trial. Controlled Clinical Trial.] Circulation 99 1999 2757 2764
18. M. Koda, G. Takemura, M. Kanoh Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure J Pathol 199 2003 229 236
19. W. Flameng, R. Suy, F. Schwarz Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease; determinants of reversible segmental asynergy post-revascularization surgery Am Heart J 102 1981 846 857
20. J. Narula, P. Pandey, E. Arbustini Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy Proc Natl Acad Sci USA 96 1999 8144 8149
21. J. Narula, R.J. Hajjar, G.W. Dec Apoptosis in the failing heart Cardiol Clin 16 1998 691 710
22. H. Milting, B. Bartling, H. Schumann Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy-first results of the Halle Assist Induced Recovery Study (HAIR) Thorac Cardiovasc Surg 47 1999 48 50
23. T. Oshiro, M. Shiraishi, Y. Muto Adenovirus mediated gene transfer of antiapoptotic protein in hepatic ischemia-reperfusion injury: the paradoxical effect of Bcl-2 expression in the reperfused liver J Surg Res 103 2002 30 36
24. J. Huang, Y. Ito, M. Morikawa Bcl-xL gene transfer protects the heart against ischemia/reperfusion injury Biochem Biophys Res Commun 311 2003 64 70
25. G. Olivetti, R. Abbi, F. Quaini Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
26. N. Haider, N. Narula, J. Narula Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling J Card Fail 8 2002 S512 S517